Topic
Bioprocess
About: Bioprocess is a research topic. Over the lifetime, 2219 publications have been published within this topic receiving 50972 citations.
Papers published on a yearly basis
Papers
More filters
••
28 May 2021
TL;DR: This review provides a comprehensive overview of the validation methods, mathematical approaches, and metrics currently applied in bioprocess modeling and points out the general issues in model validation and calibration for different types of models.
Abstract: In bioprocess engineering the Qualtiy by Design (QbD) initiative encourages the use of models to define design spaces. However, clear guidelines on how models for QbD are validated are still missing. In this review we provide a comprehensive overview of the validation methods, mathematical approaches, and metrics currently applied in bioprocess modeling. The methods cover analytics for data used for modeling, model training and selection, measures for predictiveness, and model uncertainties. We point out the general issues in model validation and calibration for different types of models and put this into the context of existing health authority recommendations. This review provides a starting point for developing a guide for model validation approaches. There is no one-fits-all approach, but this review should help to identify the best fitting validation method, or combination of methods, for the specific task and the type of bioprocess model that is being developed.
11 citations
••
01 Jan 2020TL;DR: In this chapter, advances on AD technology and MES coupling with AD are thoroughly discussed for the production of fuels and chemicals.
Abstract: Anaerobic digestion (AD) has been widely applied bioprocess to produce the biogas for fuels from organic waste degradation. AD has been integrated with other processes for increasing the digestion efficiency and waste valorization. The integration of AD with other bioprocess optimizes the production of targeted product and reduces the waste. Recently, microbial electrosynthesis (MES) was coupled with AD for the biomethane production, chemical synthesis and resource recovery. MES coupling to AD also gives an opportunity for value-added chemical generation and hence provides additional economic gains of integrated system. In MES, the remaining carbon dioxide (CO2) in biogas is reduced to methane by methanogens utilizing in situ produced hydrogen at cathode, thereby enriching methane content. Furthermore, electroactive microbes could directly accept the electron from cathode to reduce the CO2 to methane and chemicals. Therefore, CO2 fraction in the biogas could be utilized for the further chemical synthesis such as acetate, butyrate. In this chapter, advances on AD technology and MES coupling with AD are thoroughly discussed for the production of fuels and chemicals. The outputs of recent laboratory scale experiments are summarized and discussed. Furthermore, mechanism of CO2 reduction is elaborated with methane and chemical production.
11 citations
••
TL;DR: The present work paves the way for future industrial‐scale integrated continuous biomanufacturing of all types of antibodies, regardless of acid stability, with the use of a mild pH in the downstream process for the purification of acid‐sensitive monoclonal antibodies.
Abstract: In this study, we demonstrated the first, to our knowledge, integrated continuous bioprocess (ICB) designed for the production of acid‐sensitive monoclonal antibodies, prone to aggregate at low pH, on pilot scale. A high cell density perfusion culture, stably maintained at 100 × 106 cells/ml, was integrated with the downstream process, consisting of a capture step with the recently developed Protein A ligand, ZCa; a solvent/detergent‐based virus inactivation; and two ion‐exchange chromatography steps. The use of a mild pH in the downstream process makes this ICB suitable for the purification of acid‐sensitive monoclonal antibodies. Integration and automation of the downstream process were achieved using the Orbit software, and the same equipment and control system were used in initial small‐scale trials and the pilot‐scale downstream process. High recovery yields of around 90% and a productivity close to 1 g purified antibody/L/day were achieved, with a stable glycosylation pattern and efficient removal of impurities, such as host cell proteins and DNA. Finally, negligible levels of antibody aggregates were detected owing to the mild conditions used throughout the process. The present work paves the way for future industrial‐scale integrated continuous biomanufacturing of all types of antibodies, regardless of acid stability.
11 citations
••
TL;DR: In this article , the current knowledge on the introduction, overexpression, and deletion of the genes that have been performed in bacterial hosts to achieve higher ethanol yield, production rate and titer, and tolerance are discussed.
11 citations
••
TL;DR: It is demonstrated that the new strain of P. thermoglucosidasius NCIMB11955 is capable of using waste bread directly as an autoinduction carbon source for the production of terpenes in a consolidated bioprocess.
11 citations